Acute stress increases interstitial fluid amyloid-β via corticotropin-releasing factor and neuronal activity

被引:171
作者
Kang, Jae-Eun
Cirrito, John R.
Dong, Hongxin
Csernansky, John G.
Holtzman, David M.
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA
[6] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA
关键词
Alzheimer's disease; synaptic activity; environmental stress; microdialysis; transgenic;
D O I
10.1073/pnas.0700148104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aggregation of the amyloid-beta (A beta) peptide in the extracellular space of the brain is critical in the pathogenesis of Alzheimer's disease. A beta is produced by neurons and released into the brain interstitial fluid (ISF), a process regulated by synaptic activity. To determine whether behavioral stressors can regulate ISF A beta levels, we assessed the effects of chronic and acute stress paradigms in amyloid precursor protein transgenic mice. Isolation stress over 3 months increased A beta levels by 84%. Similarly, acute restraint stress increased A beta levels over hours. Exogenous corticotropin-releasing factor (CRF) but not corticosterone mimicked the effects of acute restraint stress. Inhibition of endogenous CRF receptors or neuronal activity blocked the effects of acute stress on A beta. Thus, behavioral stressors can rapidly increase ISF A beta through neuronal activity in a CRF-dependent manner, and the results suggest a mechanism by which behavioral stress may affect Alzheimer's disease pathogenesis.
引用
收藏
页码:10673 / 10678
页数:6
相关论文
共 43 条
[11]  
2-8
[12]   Cellular and molecular mechanisms of hippocampal activation by acute stress are age-dependent [J].
Chen, Y. ;
Fenoglio, K. A. ;
Dube, C. M. ;
Grigoriadis, D. E. ;
Baram, T. Z. .
MOLECULAR PSYCHIATRY, 2006, 11 (11) :992-1002
[13]   Hippocampal corticotropin releasing hormone: Pre- and postsynaptic location and release by stress [J].
Chen, Y ;
Brunson, KL ;
Adelmann, G ;
Bender, RA ;
Frotscher, M ;
Baram, TZ .
NEUROSCIENCE, 2004, 126 (03) :533-540
[14]   Synaptic activity regulates interstitial fluid amyloid-β levels in vivo [J].
Cirrito, JR ;
Yamada, KA ;
Finn, MB ;
Sloviter, RS ;
Bales, KR ;
May, PC ;
Schoepp, DD ;
Paul, SM ;
Mennerick, S ;
Holtzman, DM .
NEURON, 2005, 48 (06) :913-922
[15]  
Cirrito JR, 2003, J NEUROSCI, V23, P8844
[16]   Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia [J].
Csernansky, John G. ;
Dong, Hongxin ;
Fagan, Anne M. ;
Wang, Lei ;
Xiong, Chengjie ;
Holtzman, David M. ;
Morris, John C. .
AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (12) :2164-2169
[17]   RECIPROCAL CHANGES IN CORTICOTROPIN-RELEASING FACTOR (CRF)-LIKE IMMUNOREACTIVITY AND CRF RECEPTORS IN CEREBRAL-CORTEX OF ALZHEIMERS-DISEASE [J].
DESOUZA, EB ;
WHITEHOUSE, PJ ;
KUHAR, MJ ;
PRICE, DL ;
VALE, WW .
NATURE, 1986, 319 (6054) :593-595
[18]   Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress [J].
Dong, H ;
Goico, B ;
Martin, M ;
Csernansky, CA ;
Bertchume, A ;
Csernansky, JG .
NEUROSCIENCE, 2004, 127 (03) :601-609
[19]   Disease modifying therapy for AD? [J].
Golde, Todd E. .
JOURNAL OF NEUROCHEMISTRY, 2006, 99 (03) :689-707
[20]   Glucocorticoids increase amyloid-β and tau pathology in a mouse model of Alzheimer's disease [J].
Green, Kim N. ;
Billings, Lauren M. ;
Roozendaal, Benno ;
McGaugh, James L. ;
LaFerla, Frank M. .
JOURNAL OF NEUROSCIENCE, 2006, 26 (35) :9047-9056